Cost-Effectiveness of Magnetic Seed vs Guidewire for Breast Cancer Localization

Overview

This health economic analysis of a pragmatic RCT involving 426 patients compared magnetic seed and guidewire techniques for breast lesion localization combined with magnetic sentinel lymph node detection. Adjusted analyses demonstrated that magnetic seed localization reduced overall healthcare costs by 11.1%, driven by shorter localization and operating times despite higher device costs.

Background

Breast-conserving surgery with preoperative lesion localization and sentinel lymph node biopsy is standard for early-stage non-palpable breast cancer. Guidewire localization, while affordable, requires same-day placement and poses scheduling challenges. Magnetic seeds offer wireless localization with logistical advantages but at a higher device cost. Sentinel lymph node biopsy traditionally uses radioisotopes, but magnetic nanoparticles provide a non-radioactive alternative. The MAGTOTAL RCT evaluated a fully magnetic approach combining magnetic seed localization and superparamagnetic iron oxide nanoparticles for lymph node detection.

Data Highlights

*Adjusted for marker type, breast surgery type, and single-session lesion and SLN localization.

Key Findings

• Magnetic seed localization resulted in an 11.1% reduction in adjusted healthcare costs compared to guidewire localization.
• Device costs were higher for magnetic seeds (€278) versus guidewires (€38), but overall costs were lower due to efficiency gains.
• Magnetic seed use was associated with shorter localization and operating times, contributing to cost savings.
• Healthcare staff reported higher satisfaction and preference for magnetic seed localization.
• Sentinel lymph node detection was performed using superparamagnetic iron oxide nanoparticles, enabling a fully magnetic approach without radioisotopes.
• Sensitivity analyses confirmed the robustness of the cost savings with magnetic seeds.

Clinical Implications

Magnetic seed localization offers a cost-effective alternative to guidewire localization for non-palpable breast cancer, improving workflow efficiency and staff satisfaction without compromising clinical outcomes. Adoption of magnetic seed technology may streamline surgical scheduling and reduce operating room time, offsetting the higher upfront device cost. Integration with magnetic sentinel lymph node detection further supports a radiation-free, fully magnetic surgical approach.

Conclusion

The use of magnetic seeds for breast lesion localization combined with magnetic sentinel lymph node detection provides incremental cost containment and operational advantages over guidewire localization. These findings support the broader implementation of magnetic localization techniques in breast-conserving surgery.

References

1. MAGTOTAL RCT Study Group 2023 -- Cost-Effectiveness Comparison of Magnetic Seed and Guidewire Techniques for Breast Cancer Localization